Adil Ayub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adil Ayub has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Adnan M. Al-Ayoubi
Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.
1 shared publicationErik Lewis
Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.
1 shared publicationFaiz Bhora
Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.
1 shared publicationGrace Kim
Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.
1 shared publication- Norberto Santana-Rodríguez
Universitary Institute for Research in Biomedicine and Health (IUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain
1 shared publication Sadiq Rehmani
Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.
1 shared publication
Latest Publications
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2581-2586
Primary Non-Hodgkin’s Lymphoma of the Gallbladder: Α Population-based Analysis
Background/Aim: Primary Non-Hodgkin's lymphoma of the gallbladder (PNHL-GB) is extremely rare and data on clinical characteristics, optimal management and outcomes of these patients are limited to anecdotal reporting. We, therefore, sought to examine these patients using a population-based database. Materials and Methods: Surveillance, epidemiology, and end results (SEER) database was queried between 1973 and 2013. Results: One hundred and six cases with PNHL-GB were identified (mean age=70.5 ±15 years, whites 92%, male: female 1.03:1). The majority of patients had loco-regional disease (61%) and DLBCL histology (33%). Ninenty cases (85%) had undergone surgical resection, 6 (5.6%) received radiotherapy. Median overall survival (OS) of the entire cohort was 41 months with a 5-year survival rate of 40%. Patients receiving adjuvant RT had superior OS compared to surgery alone (140 ±27 vs. 86 ±16 months, respectively) and patients with DLBCL demonstrated lower survival compared to other histologies (13 vs. 53 months, respectively, p=0.034). Conclusion: Our study presents the largest dataset of PNHL-GB describing clinical features and outcomes of these patients in addition to summarizing the literature.
- 7 May 2017
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (5) , 2581-2586
Primary Non-Hodgkin’s Lymphoma of the Gallbladder: Α Population-based Analysis
Background/Aim: Primary Non-Hodgkin's lymphoma of the gallbladder (PNHL-GB) is extremely rare and data on clinical characteristics, optimal management and outcomes of these patients are limited to anecdotal reporting. We, therefore, sought to examine these patients using a population-based database. Materials and Methods: Surveillance, epidemiology, and end results (SEER) database was queried between 1973 and 2013. Results: One hundred and six cases with PNHL-GB were identified (mean age=70.5 ±15 years, whites 92%, male: female 1.03:1). The majority of patients had loco-regional disease (61%) and DLBCL histology (33%). Ninenty cases (85%) had undergone surgical resection, 6 (5.6%) received radiotherapy. Median overall survival (OS) of the entire cohort was 41 months with a 5-year survival rate of 40%. Patients receiving adjuvant RT had superior OS compared to surgery alone (140 ±27 vs. 86 ±16 months, respectively) and patients with DLBCL demonstrated lower survival compared to other histologies (13 vs. 53 months, respectively, p=0.034). Conclusion: Our study presents the largest dataset of PNHL-GB describing clinical features and outcomes of these patients in addition to summarizing the literature.